Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
about
Differential Co-Expression between α-Synuclein and IFN-γ Signaling Genes across Development and in Parkinson’s DiseaseGenetic perspective on the role of the autophagy-lysosome pathway in Parkinson diseaseGlucocerebrosidase is shaking up the synucleinopathiesGenetic association of RIT2 rs12456492 polymorphism and Parkinson's disease susceptibility in Asian populations: a meta-analysisA conserved role for p48 homologs in protecting dopaminergic neurons from oxidative stressPARK10 is a major locus for sporadic neuropathologically confirmed Parkinson diseaseRIT2, a neuron-specific small guanosine triphosphatase, is expressed in retinal neuronal cells and its promoter is modulated by the POU4 transcription factorsLarge-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's diseaseParkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expressionSerum iron levels and the risk of Parkinson disease: a Mendelian randomization study.Identification of a novel Parkinson's disease locus via stratified genome-wide association studyGBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysisIdentification of genetic modifiers of age-at-onset for familial Parkinson's diseaseTracking Parkinson's: Study Design and Baseline Patient Data.Systems-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanismsGene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation.A comparison of gene region simulation methods.Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening.The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.Genetic variability in the regulation of gene expression in ten regions of the human brain.Evaluation of Parkinson disease risk variants as expression-QTLs.Genome-wide association studies in neurology.Genetic variations of GAK in two Chinese Parkinson's disease populations: a case-control study.Genetic association study between STK39 and CCDC62/HIP1R and Parkinson's diseaseEffective variant detection by targeted deep sequencing of DNA pools: an example from Parkinson's disease.Targeting GTPases in Parkinson's disease: comparison to the historic path of kinase drug discovery and perspectivesHigh-throughput functional screening using a homemade dual-glow luciferase assay.Vitamin D from different sources is inversely associated with Parkinson disease.Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson diseaseGBA mutations are associated with Rapid Eye Movement Sleep Behavior DisorderThe 4p16.3 Parkinson Disease Risk Locus Is Associated with GAK Expression and Genes Involved with the Synaptic Vesicle Membrane.Evolution of neurodegeneration.A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.Association analysis of HLA-DRA in Chinese patients with sporadic Parkinson's disease.Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.The Evolution of Genetics: Alzheimer's and Parkinson's Diseases.The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease.eSNPO: An eQTL-based SNP Ontology and SNP functional enrichment analysis platformStrong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.
P2860
14e9315116ecdcd4548fe82bfc9525323007c1271a13202c69f4c7a177dedc4db8fa511786133cc84d5826fcfa9971bda29317767158c21ee0d5f91351651cad36d7f6b51798c6491524d43b2b3eed1259f6903417047c73bb1c996594f2ec9285cd2d7374c762777c2af9b56d15eb18d1a7f41e7c139ac5d8cd8902e3865d15ab0543f59837bdca705acd75fcc42e9a14cd39cb513803ab6e5a165872d6b03a
P248
Q21090572-FAC86F44-2CF2-4B35-B50A-5A94030DB847Q22242985-D7CD1112-38F2-4FD3-BAD9-1CF94F7209CAQ24337392-89439823-3E99-4AEA-AF32-AB008E6F1024Q26786221-5D4DDA27-5726-4A4D-9E85-BC5FBF041EC5Q27312249-C5B67F3E-D6A9-4EF5-A90E-62BF5D593612Q27349225-81449E01-C8B9-4278-BB69-579B508A6270Q28115164-19A651D6-39F6-4F05-8166-009BC40B5F05Q28244731-40DF1BD9-0C4C-412E-A7B0-89C892A17385Q28598223-8F227001-565C-4F1A-8A58-BC95D607DA29Q28681958-6421ED51-2B09-4FA5-8B01-1083EE8A51E6Q30571934-9FAC7BD4-3234-4833-A889-613408376A9AQ30700188-6994E0F2-22B4-464B-96F8-E6B6BDFB0005Q30833019-EA1A210E-CEDF-4206-A4AC-CE480A3F348FQ30833988-E12B4DB2-6236-49C6-9040-763AEB136786Q31008758-75070311-33B7-4345-BA91-A89BC364EE8DQ34109658-40CD0301-2A51-44AF-87DF-2B605B4C1168Q34325576-E153039F-17EC-479E-AA43-04E65E2F8423Q34345416-DD523555-168A-4A2D-AE49-AD5F5CD014A6Q34356116-66C07065-07AE-4FD3-9789-605A4788BAE2Q34398442-15A1E851-88AA-4748-956D-C183D4FD881CQ34398489-4483BE25-83CF-4D4A-9C81-445BCCA52DE9Q34446993-E413502B-38D9-42D3-8819-EDBFA3FFCE38Q34658391-CDB737B7-C8F7-4F78-8B12-4C020DA2B526Q34797291-2DA489B5-C0BD-4E6A-9A79-B668EC138FBAQ35060173-3DEA2E3D-E6C8-472B-A5DF-AFD6DE6DE684Q35128698-ECF28A63-1A92-4E7D-BE92-B27837B6A957Q35187475-2950C702-C09B-46EF-92E9-75AF2A5598B0Q35194347-9615DB0B-E7F7-4DE1-BDF4-0F3FFC678660Q35327512-608516DF-6F41-4EC3-A1A7-899CB6DEA621Q35899904-CBAA9040-BD02-48D0-932F-147BF01FB511Q36072435-1B452E5F-5BA7-4184-8CDD-4005E5038563Q36100136-0ED91113-30F2-4468-B290-CF8233A6D3FEQ36325667-8777F4C3-A722-4AAC-82EA-427BCC24259CQ36370223-1749DB33-381C-4A58-97BD-B1BA9E89DD09Q36678644-243444F0-EAAC-45BD-9AD0-FBABC1FF1133Q36815405-FB1DBCE7-7593-4548-AA1A-6D50F1CBF775Q37074331-1C5E443F-A4E5-40FB-8247-A845A546EA37Q37082285-0A5A0C12-EB85-4B38-952B-652E8290B756Q37137308-83E33047-79BF-47DF-931F-B0B429C72A40Q37170658-9D2ADCE0-83AF-4724-A83E-0BC2441AE46A
P2860
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2
@nl
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
@ast
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
@en
type
label
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2
@nl
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
@ast
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
@en
prefLabel
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2
@nl
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
@ast
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
@en
P2093
Adrian J Ivinson
Albert Y Hung
Clemens R Scherzer
David K Simon
Dmitri Krainc
Eden R Martin
Gary W Beecham
Haydeh Payami
Karen Marder
Kimberly F Doheny
P2860
P304
P3181
P356
10.1002/ANA.22687
P407
P50
P577
2012-03-01T00:00:00Z